Oxford University’s Covid jab becomes “vaccine for the world” with 2 billion doses – World News

Exclusive:

A groundbreaking approach meant that Oxford University’s Covid jab was quickly produced in poorer countries around the world as researchers insisted that the vaccine be sold at a profit and quickly set up a McDonald’s-style franchise system.

Dr. Sandy Douglas
Dr. Sandy Douglas led the team that made the discovery

Two billion doses of Oxford University’s Covid jab have now been produced as of today thanks to a lab breakthrough that made it the “world vaccine”.

The milestone marks the global takeover of British jabs using a groundbreaking method that meant it was rapidly produced in poorer countries around the world.

China’s Sinovac vaccine alone has been administered in more arms globally, mainly because it is the number one vaccine for the country’s 1.4 billion population.

Oxford’s AstraZeneca jab has been the main Covid-19 lifeline for Africa, the Indian subcontinent, large parts of the Middle East, South and Central America, as well as Australia and the United Kingdom.

Researchers insisted that the vaccine be sold at a profit and quickly set up a McDonalds-style franchise system to establish low-tech manufacturing labs in 15 countries.








The vital Oxford jab
(

Picture:

Huddersfield Examiner)



The discovery was made by a team led by Dr Sandy Douglas and they recently received a Special Recognition gong at the Mirror’s Pride of Britain Awards.

Dr Douglas told the Mirror that from the beginning they were convinced that theirs would be “the world’s vaccine”.

He said: “We looked around the world and knew a little bit of the history of what had happened to access to vaccines in previous pandemics, which is that countries have fought with each other for access.

“We foresaw that the less well-off countries could very well fall behind and we thought it was a high priority to address it from the outset.

“There were two things we strived for when we tried to make the right choice [pharmaceutical] partner.

“One of them was the non-profit aspect. The other was the question of where the vaccine would be manufactured because we were worried that the holding would be nine tenths of the law.”





Oxford academics contacted factory owners with suitable locations around the world and persuaded them to start preparing to make the vaccine, even before it had been given to the first volunteer in the clinical trial.

These manufacturing facilities, including in India and South America, have meant that rich nations could not monopolize supplies of their jab.

The most important mass production technology, which meant that Oxford jab could be manufactured and stored in existing labs, was confirmed in a breakthrough on 29 January.

A vaccine – in the form of an inactivated form of the virus – must grow inside cells.

The Oxford team found a specific mixture of nutrients that could be “fed” to the cells to keep them healthy.

It allows many more doses to be made in each batch and, crucially, avoids the need for complex equipment to keep the cells healthy, which is required for other vaccines.




The combination of new technology and the franchise model meant that in addition to being Britain’s workhorse vaccine – inoculating Britons faster than almost any other comparable nation – the Oxford jab has been able to protect more of the world’s poorest communities from the ravages of pandemics. . It is now used in 181 countries, by most.

It was the main vaccine that could penetrate in significant quantities to conflict-affected parts of the world such as Syria and Iraq.

After the Oxford jab, Pfizer has produced most of their jab. However, these doses have almost exclusively gone to the United States, Europe and Israel.

Oxford jab is the only vaccine that has committed to be sold without profit to all countries during the pandemic, and without profit to poorer countries forever.

Sir John Bell, from the UK Vaccine Taskforce and Oxford University, said: “Manufacturing may not be seen as glamorous but the number of doses made, and where they are made, determines how much impact a vaccine can have on the real world.

“Millions of people around the world owe their lives to the two billion doses produced as a result of this collaboration between our researchers and AstraZeneca.”


Read more




Read more



.

x